Innvolution Healthcare Private Limited (IHPL) has been recently granted the CDSCO manufacturing license for its Cardiac catheterisation laboratory (cath lab) facility in Andhra Pradesh MedTech Zone (AMTZ).

The facility, recently inaugurated by the Union Minister of Commerce and Industry, Piyush Goyal, represents a strategic move toward bolstering India’s domestic capacity to produce advanced cardiac imaging systems.

The development comes at a time when the nation’s cardiovascular infrastructure faces a severe deficit, while the cardiovascular diseases are claiming nearly three million lives annually and impacting nearly 80 million patients. India currently hosts only about 4,000 active cardiac catheterisation labs, a limitation that has historically restricted access to advanced cardiac care.

Experts believe that shifting from expensive imported systems to domestic manufacturing will be pivotal in enhancing hospital affordability and expanding the reach of life-saving treatments.

Global market outlook

The cardiac care segment is recognised as one of India’s fastest-growing medical device markets and on the global stage, the market for cardiac cath lab equipment and consumables is projected to grow from approximately $30-32 billion in 2026 to $50-55 billion over the coming decade.

Proponents of the project note that the local production of these high-quality, sophisticated systems is expected to strengthen supply chains, create skilled employment opportunities, reduce import dependency, and enhance India’s global competitiveness in medical technology.

Dr. Jitendra Sharma, MD and Founder CEO of AMTZ, hailed the achievement as a reflection of the growing maturity of the country’s MedTech ecosystem. “At AMTZ, we remain committed to enabling world-class innovation and manufacturing that positions India as a global leader in advanced medical technologies,” he said.

Gaurav Agarwal, Managing Director of Innvolution Healthcare Private Limited, highlighted the importance of the collaborative environment at the zone. “The infrastructure and support available at AMTZ have enabled us to establish our Cath Lab manufacturing facility, and we remain committed to delivering reliable, high-quality solutions that meet the evolving needs of India’s healthcare sector,” Mr. Agarwal stated.